Document is current
Any future updates will be listed below
-
Authors
Al Khayat, Mohamed N. M. T. https://orcid.org/0000-0002-3442-2936
Armstrong, Nigel
Howick, Jeremy
O’Meara, Susan
Posadzki, Pawel
Ryder, Steve
Ahmadu, Charlotte
Konings, Stefan R. A.
Postma, Maarten J.
Duffy, Steven
Wolff, Robert F.
van Asselt, Antoinette D. I.
-
Funding
Funding for this research was provided by:
Health Technology Assessment Programme (NIHR135136)
- License Information
-
More Information
Article History
Accepted: 24 January 2023
First Online: 9 February 2023
Declarations
:
: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (award ID NIHR135136). Please visit the HTA programme website for further project information ().
: MA, NA, JH, SO, PP, SR, CA, SK, MP, SD, RW, AvA have no conflicts of interest to declare.
: All authors have commented on the submitted manuscript and have given their approval for the final version to be published. JH, PP, NA, and SO critiqued the clinical effectiveness data reported by the company. SD critiqued the literature searches undertaken by the company. MA, CA, SK, MP, NA, and AvA critiqued the mathematical model provided and the cost-effectiveness analyses submitted by the company. RW critiqued the company’s definition of the decision problem and their description of the underlying health problem and current service provision. AvA acts as overall guarantor for this article. This article has not been externally peer reviewed by PharmacoEconomics.
